Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Puma Biotechnology, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PBYI: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders8978−11
Shares27.5M27.8M+296.2K (+1.1%)
Value$116.3M$86.1M−$30.3M (−26.0%)

New holders (10)

Institutions that held Puma Biotechnology, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to PBYI in Q1 2023
InstitutionSharesValue% of portfolio
Affinity Asset Advisors, LLC177,349$548.0K0.21%
Cornercap Investment Counsel Inc124,919$386.0K0.07%
Caxton Associates LP24,610$76.0K0.01%
Wolverine Trading, LLC12,944$37.0K0.00%
Lighthouse Investment Partners, LLC11,276$34.8K0.00%
Point72 Asset Management, L.P.11,000$34.0K0.00%
Simplex Trading, LLC10,367$32.0K0.00%
Group One Trading, L.P.3,733$11.5K0.00%
Quantbot Technologies LP3,600$11.1K0.00%
Tucker Asset Management LLC126$3890.00%

Sold out (21)

Institutions that held Puma Biotechnology, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.